Develop New Product Candidate For Vulvar Lichen Sclerosus
Jan 18 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS BROADENS PIPELINE WITH NEW PRODUCT CANDIDATE FOR
VULVAR
LICHEN SCLEROSUS (VLS)
* HAS ENTERED INTO A PARTNERSHIP WITH AFT PHARMACEUTICALS
(AFT) TO
DEVELOP A NOVEL MUCOADHESIVE FILM FOR TREATMENT OF VULVAR LICHEN
SCLEROSUS
Source text for Eikon: ID:nGNE6kdq63
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million